The identification of risk factors for cardiovascular diseases
The identification of risk factors for cardiovascular diseases
Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa.
ЧИТАТЬ ДАЛЕЕ ...
The identification of risk factors for cardiovascular diseases Cardiovascular diseases (CVD) are one of the leading causes of death worldwide. The identification and analysis of risk factors plays a crucial role in the prevention and early Intervention to reduce the incidence and mortality of these diseases. Primary Risk Factors The primary modifiable risk factors include: Arterial hypertension: A permanently elevated blood pressure (≥140/90 mmHg) charged to the vessels of the heart and the blood and increases the risk for heart attack and stroke significantly. Dyslipidemia: An unhealthy lipid constellation, in particular, an elevated total cholesterol and LDL‑cholesterol and a low HDL‑cholesterol, promotes atherosclerosis development. Tobacco use: cigarette Smoking leads to vasoconstriction, increased thrombus formation and accelerated atherosclerosis. Diabetes mellitus: in Particular, type 2 Diabetes is associated with an increased risk for CVD, since it causes damage to the vascular wall, and metabolic disturbances caused. Overweight and obesity: An increased Body Mass Index (BMI ≥25 kg/m 2 ), and in particular the Central adipose tissue increase the load on the cardiovascular System. Lack of exercise: A low physical activity promotes Obesity, hypertension and dyslipidemia and reduce cardiovascular Fitness. Unhealthy diet: A high intake of saturated fatty acids, TRANS fats, sugar and salt, as well as a lack of fiber, fruits and vegetables, can promote the development of risk factors. Non-modifiable risk factors Some risk factors you can't control, but must be in the individual risk assessment takes into account: Age: With age, the risk for CVD is increasing exponentially. Gender: men generally have a higher risk of early cardiovascular events; after Menopause, the risk in women approaches that of men. Genetic predisposition: A family history of early cardiovascular disease (in men before the age of 55. Age, and in women before the age of 65. Years of age), increases the individual's risk. Other relevant factors Increasingly, other aspects to be investigated as potential risk factors: Psychosocial Stress: Chronic Stress, Depression, and social Isolation can increase the neuro-endocrine mechanisms of the risk. Sleep disorders: in Particular, obstructive sleep apnea is associated with hypertension and arrhythmic events. Air pollution: long-term pollution by fine particles (PM2.5) seems to increase the cardiovascular risk. Methods of risk factor identification The identification is done by: A history of collection: collection of lifestyle factors, medical conditions and family medical history. Physical examination: measurement of blood pressure, BMI, waist circumference. Laboratory analyses: blood tests to determine cholesterol (LDL, HDL, triglycerides), blood sugar, HbA1c and inflammatory markers (e.g. C‑reactive Protein). Instruments for risk assessment: use of Scores such as the SCORE algorithm (Systematic COronary Risk Evaluation) for the calculation of the 10‑year risk of a fatal cardiovascular event. Conclusion The systematic identification of risk factors allows for a targeted prevention of cardiovascular diseases. Through the modification of lifestyle factors, and medical control of hypertension, Diabetes and dyslipidemia, the individual and societal risk can be significantly reduced. Regular health examinations, and education of the population, are of Central importance. Would you like me to make a certain section in greater detail or further Details about a range of topics to add?
Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa. The identification of risk factors for cardiovascular diseases. Ang Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay.
Table in cardiovascular diseases
Potassium for high blood pressure
The dead of cardiovascular diseases
http://gumbaz.ru/posts/818082-diseases-of-the-organs-of-the-cardiovascular-system.html
http://zavodyrossii.ru/posts/11135-tablets-of-hypertension-prices.html
Sa pangunahing (esensyal) na altapresyon, ito ay dahil sa impluwensya ng namamana, hilig sa mataas na presyon ng dugo sa konteksto ng hindi malusog na pamumuhay, masamang gawi, hindi malusog na pagkain, na nagdudulot ng labis na timbang. Dagdag pa ang stress, kalikasan, kakulangan sa tulog at aktibidad. Lahat ito ay negatibong nakakaapekto sa trabaho ng puso at sa tono ng mga daluyan ng dugo. Ang presyon ay unang tumataas nang hindi napapansin at pagkatapos ay mas nagiging malinaw. If you have disturbed sleep, fatigue, disorientation, confusion, or nervousness, it's time to monitor your blood pressure. Either lack of sleep or too much sleeping might mean your blood pressure is high or low. If it’s left untreated, you will soon face an onslaught of multiple illnesses.
The last pills for high blood pressure: New developments in the pharmacotherapy High blood pressure, known medically as hypertension, is one of the most common chronic diseases worldwide and is considered to be the main cause for cardiovascular diseases, strokes, and kidney damage. The WHO estimates that over a billion people suffer from hypertension, which is why the development of effective therapies is of high relevance. State-of-the conventional therapy The current guidelines (e.g., the European Society of Cardiology, ESC) recommend as a first‑line therapy, a combination of different classes of Drugs: ACE inhibitors (eg, Lisinopril) — block the Angiotensin‑converting enzymes, thereby lowering the blood pressure; AT1‑Receptor antagonists (known as Sartans, e.g., Losartan) — inhibit the action of Angiotensin II; Calcium channel blockers (e.g. amlodipine) — lead vessels to a relaxation of the blood; Diuretics (such as hydrochlorothiazide) to promote the excretion of water and salt; Beta-blockers (e.g., Metoprolol) — decrease of ejection and the heart rate and the Heart. Despite these many options, the patient's blood pressure remains at about 30%, despite multiple medication is not adequately controlled (resistant hypertension). This motivates the search for new drugs and therapeutic approaches. The latest developments and innovative pills In recent years, several novel agents have been developed that operate on different biochemical levels: Endothelin Receptor Antagonists (ERAs) Substances such as Atrasentan inhibit the vasoconstrictor effect of Endothelin‑1 and a significant blood show in studies pressure reduction, especially in patients with chronic kidney disease. Renin Inhibitors Aliskiren was the first direct Renin Inhibitor, however, with limited application because of possible side effects. Current analogues with improved safety profiles are currently being tested in clinical trials. Neprilysin inhibitors in combination with Sartans The fixed combination of Sacubitril (a Neprilysin inhibitor) and Valsartan (an AT1 Receptor Antagonist), is already approved for the treatment of congestive heart failure and hypertension good results. Antisense oligonucleotides against Angiotensinogen This innovative strategy aims to block the synthesis of Angiotensinogen in the liver. In early studies, it was shown a long — lasting blood pressure control after only one injection, a potential breakthrough for patients with poor medication adherence. Dual‑Active Compounds (Single‑Pill Combinations) New formulations combine two or even three active ingredients in one tablet (for example, amlodipine + Valsartan + hydrochlorothiazide), what is the therapy increases easier and the patient's adherence. Challenges and perspectives Although these new therapies are promising, there remain challenges: Long‑term safety and side effect profiles need to be further investigated; the cost of such innovative drugs are often high; individual therapy adjustment remains essential, not every new pill is suitable for each patient. In summary, we can say that the pharmacotherapy of hypertension has evolved. The latest pills and strategies, particularly for patients with resistant hypertension, a new hope. At the same time, the combination of drugs, remains a style change, and regular measurement of blood pressure life is the Foundation of a successful long-term therapy.